408
Views
27
CrossRef citations to date
0
Altmetric
Theme: Vascular Disease - Review

Diagnosis and treatment of severe hypertriglyceridemia

&
Pages 505-514 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Oluwayemisi Esan & Anthony S Wierzbicki. (2020) Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy. Drug Design, Development and Therapy 14, pages 2623-2636.
Read now
Rabia Chaudhry, Adie Viljoen & Anthony S. Wierzbicki. (2018) Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome. Expert Review of Clinical Pharmacology 11:6, pages 589-598.
Read now
Anthony S. Wierzbicki & Adie Viljoen. (2016) Anti-sense oligonucleotide therapies for the treatment of hyperlipidaemia. Expert Opinion on Biological Therapy 16:9, pages 1125-1134.
Read now
Anthony S Wierzbicki & Adie Viljoen. (2013) Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency. Expert Opinion on Biological Therapy 13:1, pages 7-10.
Read now

Articles from other publishers (23)

Fahad Aziz, Ramin Sam, Susie Q. Lew, Larry Massie, Madhukar Misra, Maria-Eleni Roumelioti, Christos P. Argyropoulos, Todd S. Ing & Antonios H. Tzamaloukas. (2023) Pseudohyponatremia: Mechanism, Diagnosis, Clinical Associations and Management. Journal of Clinical Medicine 12:12, pages 4076.
Crossref
Irina I. Pshenichnikova, Irina N. Zakharova, Ismail M. Osmanov, Inna I. Trunina, Viktoria V. Pupykina, Indira Kh.-B. Arsel'gova, Yulia V. Koba, Tatiana I. Bocharova & Aia R. Abazova. (2023) Familial chylomicronemia syndrome in children and adolescents: diagnosis and treatment. Pediatrics. Consilium Medicum:4, pages 358-360.
Crossref
Daniele Tramontano, Simone Bini, Laura D’Erasmo & Marcello Arca. (2022) Recent Apolipoprotein CIII trials. Current Opinion in Lipidology 33:6, pages 309-318.
Crossref
Zachary S. Jarrett, Chung-ting J. Kou, WingYee Wan & Jeffery A. Colburn. (2022) The Use of Orlistat in an Adult with Lipoprotein Lipase Deficiency: A Case Report. AACE Clinical Case Reports 8:2, pages 93-95.
Crossref
Xi May Zhen, Kuo Luong Lee, David Sullivan & Shamasunder Acharya. (2021) New diagnosis of diabetes and severe hyperlipidemia at 3 months postpartum presenting as florid diabetic retinopathy and eruptive xanthomas. Journal of Obstetrics and Gynaecology Research 48:2, pages 483-491.
Crossref
Xuyun Hu, Lamei Chen, Chunxiu Gong, Jun Guo, Yuanying Chen, Quan Wang, Ruolan Guo, Wei Li & Chanjuan Hao. (2021) Whole exome sequencing for non-selective pediatric patients with hyperlipidemia. Gene 768, pages 145310.
Crossref
Rami A. Ballout & Alan T. Remaley. 2021. Biochemical and Molecular Basis of Pediatric Disease. Biochemical and Molecular Basis of Pediatric Disease 965 1022 .
Andrea Manni & Akuffo QuardeAndrea Manni & Akuffo Quarde. 2020. Endocrine Pathophysiology. Endocrine Pathophysiology 171 185 .
Anthony S. Wierzbicki & Timothy M. Reynolds. (2019) Genetic risk scores in lipid disorders. Current Opinion in Cardiology 34:4, pages 406-412.
Crossref
Eliza Christopoulou, Moses Elisaf & Theodosios Filippatos. (2019) Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes. Disease Markers 2019, pages 1-8.
Crossref
Beatriz Corredor-Andrés, María Teresa Muñoz-Calvo, Olga Calero, Cristina Aparicio, Jesús Argente & Miguel Calero. (2018) Nephrotic syndrome associated with severe hypertriglyceridemia in a pediatric patient: Answers. Pediatric Nephrology 33:11, pages 2075-2078.
Crossref
Anthony S. Wierzbicki. 2018. Endocrine and Metabolic Medical Emergencies. Endocrine and Metabolic Medical Emergencies 742 759 .
W. Timothy Garvey, Jeffrey I. Mechanick, Elise M. Brett, Alan J. Garber, Daniel L. Hurley, Ania M. Jastreboff, Karl Nadolsky, Rachel Pessah-Pollack & Raymond Plodkowski. (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity. Endocrine Practice 22, pages 1-203.
Crossref
W. Timothy Garvey, Gillian Arathuzik, Gary D. Miller & Jamy Ard. 2016. Lifestyle Medicine. Lifestyle Medicine 245 267 .
A. Viljoen & A. S. Wierzbicki. (2015) Improving the odds: ezetimibe and cardiovascular disease. International Journal of Clinical Practice 69:4, pages 390-395.
Crossref
Terry A. Jacobson, Matthew K. Ito, Kevin C. Maki, Carl E. Orringer, Harold E. Bays, Peter H. Jones, James M. McKenney, Scott M. Grundy, Edward A. Gill, Robert A. Wild, Don P. Wilson & W. Virgil Brown. (2015) National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report. Journal of Clinical Lipidology 9:2, pages 129-169.
Crossref
Marcelo J. A. Amar, Toshihiro Sakurai, Akiko Sakurai-Ikuta, Denis Sviridov, Lita Freeman, Lusana Ahsan & Alan T. Remaley. (2015) A Novel Apolipoprotein C-II Mimetic Peptide That Activates Lipoprotein Lipase and Decreases Serum Triglycerides in Apolipoprotein E–Knockout Mice. Journal of Pharmacology and Experimental Therapeutics 352:2, pages 227-235.
Crossref
Olga Diakoumakou, Georgios Hatzigeorgiou, Nikos Gontoras, Maria Boutsikou, Vana Kolovou, Sophie Mavrogeni, Vassiliki Giannakopoulou & Genovefa D. Kolovou. (2014) Severe/Extreme Hypertriglyceridemia and LDL Apheretic Treatment: Review of the Literature, Original Findings. Cholesterol 2014, pages 1-9.
Crossref
Yeunjung Kim & Michael Miller. (2014) Marked hypertriglyceridemia in a woman receiving metoprolol succinate. Journal of Clinical Lipidology 8:6, pages 640-643.
Crossref
R Hajhosseiny, I Sabir, K Khavandi & A S Wierzbicki. (2014) The Ebbs and Flows in the Development of Cholesterol-Lowering Drugs: Prospects for the Future. Clinical Pharmacology & Therapeutics 96:1, pages 64-73.
Crossref
Peter J. Little, Alan Chait, Andrzej S. Januszewski, Alex Bobik, David O’Neal & Alicia J. Jenkins. 2014. Lipoproteins in Diabetes Mellitus. Lipoproteins in Diabetes Mellitus 435 453 .
Rawad Mounzer & David C. Whitcomb. (2013) Genetics of acute and chronic pancreatitis. Current Opinion in Gastroenterology 29:5, pages 544-551.
Crossref
James Barnett, Adie Viljoen & Anthony S. Wierzbicki. (2013) The Need for Combination Drug Therapies in Patients with Complex Dyslipidemia. Current Cardiology Reports 15:8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.